Kiora Pharmaceuticals Inc Cash Flow-to-Debt Ratio
Kiora Pharmaceuticals Inc cash flow-to-debt ratio. Kiora Pharmaceuticals Inc (KPRX) has a Cash Flow-to-Debt Ratio of -0.27x as of June 2026, meaning its operating cash flow of $-1.89 Million could theoretically repay 0% of its total liabilities ($6.92 Million) in one year. Check Kiora Pharmaceuticals Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Kiora Pharmaceuticals Inc (2012–2025)
Cash flow-to-debt ratio of Kiora Pharmaceuticals Inc from 2012 to 2025. Historical debt coverage capacity for Kiora Pharmaceuticals Inc across 14 annual periods. Check KPRX cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Kiora Pharmaceuticals Inc Cash Flow-to-Debt Ratio by Year (2012–2025)
Kiora Pharmaceuticals Inc cash flow-to-debt ratio by year from 2012 to 2025. Year-by-year debt coverage analysis for Kiora Pharmaceuticals Inc. For the full cash flow conversion analysis, see KPRX cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.23x | $-9.96 Million | $8.13 Million | ▼ -253.6% |
| 2024 | 0.80x | $8.56 Million | $10.72 Million | ▲ +163.5% |
| 2023 | -1.26x | $-9.56 Million | $7.60 Million | ▲ +12.4% |
| 2022 | -1.43x | $-10.43 Million | $7.27 Million | ▲ +25.4% |
| 2021 | -1.92x | $-10.68 Million | $5.55 Million | ▼ -46.5% |
| 2020 | -1.31x | $-7.32 Million | $5.57 Million | ▲ +43.8% |
| 2019 | -2.34x | $-8.15 Million | $3.49 Million | ▼ -15.1% |
| 2018 | -2.03x | $-10.84 Million | $5.34 Million | ▼ -409.2% |
| 2017 | -0.40x | $-6.47 Million | $16.23 Million | ▲ +52.3% |
| 2016 | -0.84x | $-8.41 Million | $10.06 Million | ▲ +35.8% |
| 2015 | -1.30x | $-4.46 Million | $3.42 Million | ▼ -5581.3% |
| 2014 | -0.02x | $-950.62K | $41.43 Million | ▲ +69.8% |
| 2013 | -0.08x | $-2.96 Million | $38.98 Million | ▲ +46.0% |
| 2012 | -0.14x | $-5.22 Million | $37.16 Million | — |